Herpes Zoster (Shingles) - Immediate Antiviral Treatment Required
This presentation of new-onset numbness, tingling from elbow through hand with a painful rash along the ulnar aspect of the forearm is highly consistent with herpes zoster (shingles) affecting the ulnar nerve distribution, and you must initiate antiviral therapy within 72 hours of rash onset to prevent postherpetic neuralgia.
Immediate Management Algorithm
1. Confirm Clinical Diagnosis
- Dermatomal distribution: Unilateral rash following ulnar nerve territory (C8-T1 dermatome)
- Characteristic rash: Vesicular eruptions, typically preceded by burning pain and dysesthesia 1, 2, 3
- Sensory symptoms: Numbness, tingling, burning pain along the affected dermatome
- Key distinguishing feature: Pain typically precedes rash by several days 4
2. Initiate Antiviral Therapy Immediately (Within 72 Hours)
First-line antiviral options 5, 4:
- Valacyclovir: Higher doses appropriate for VZV (preferred for convenience)
- Famciclovir: Alternative with similar efficacy
- Acyclovir: Oral or IV (if severe/complicated)
Treatment duration: Minimum 7-10 days 5
Critical timing: Most effective when started within 72 hours of rash onset 4, 6
3. Assess for Complicated Disease
Discontinue immunosuppressive therapy if present 5:
- Severe varicella infection
- Disseminated HSV/VZV
- Multi-dermatomal involvement
- Visceral involvement
Consider IV acyclovir for 5:
- Multi-dermatomal distribution
- Ophthalmic involvement
- Visceral or disseminated disease
- Immunocompromised patients
4. Symptomatic Pain Management
- Gabapentin or pregabalin: For neuropathic pain component
- Tricyclic antidepressants (e.g., nortriptyline): Dual benefit for pain and PHN prevention
- Analgesics: According to WHO pain ladder as needed
- Consider short-course corticosteroids: Prednisone 0.5-1 mg/kg for 7 days may provide modest benefit in reducing acute pain 4
Interventional option for severe acute pain 1:
- Stellate ganglion blockade can provide rapid pain relief (50% reduction within minutes) and improve drug therapy compliance in upper extremity distribution
5. Prevention of Postherpetic Neuralgia (PHN)
Key preventive measures:
- Early antiviral therapy (within 72 hours) 4, 6
- Adequate acute pain control
- Consider tricyclic antidepressants early 4
- Restart immunosuppression only after skin vesicles have resolved and patient is on anti-VZV therapy 5
6. Monitor for Complications
Postherpetic neuralgia risk factors 4, 6:
- Age (increases with advancing age)
- Severity of acute pain
- Extent of rash
- Immunosuppression
PHN definition: Persistent pain or dysesthesia ≥1 month after rash resolution 2
Common Pitfalls to Avoid
Delaying antiviral therapy: The 72-hour window is critical - don't wait for confirmatory testing 4, 6
Mistaking for other conditions 2, 3, 7:
- Ulnar nerve entrapment/neuropathy
- Lateral epicondylitis
- Radial tunnel syndrome
- Cervical radiculopathy
- Brachioradialis muscle pain
Key differentiator: The presence of vesicular rash in dermatomal distribution is pathognomonic for herpes zoster
Starting steroids before ophthalmology evaluation: If any ocular involvement suspected, steroids may worsen herpetic keratitis/uveitis 8
Inadequate pain control: Undertreating acute pain increases PHN risk 6
Missing immunocompromised state: These patients require more aggressive treatment and may need IV therapy 5
Special Considerations
Herpes zoster prophylaxis 5, 9:
- Important for patients on bortezomib and steroid combinations
- Consider in immunosuppressed patients
- Isolated ulnar dorsal cutaneous nerve involvement can occur
- Pain may be the only initial symptom before rash appears
- Regressed or atypically located lesions may make diagnosis challenging
If rash has already resolved: Treatment focuses on neuropathic pain management with gabapentin, pregabalin, or tricyclic antidepressants, with interventional options (pulsed radiofrequency of dorsal root ganglion) for refractory cases 6